Medigen Vaccine Biologics Corporation (TPEX:6547)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
48.00
+0.40 (0.84%)
Apr 29, 2026, 1:30 PM CST

Medigen Vaccine Biologics Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
15,64812,41011,85123,03522,78563,653
Upgrade
Market Cap Growth
-1.35%4.72%-48.55%1.10%-64.20%192.75%
Upgrade
Enterprise Value
14,16011,03510,38221,27120,54062,660
Upgrade
Last Close Price
47.6037.7536.0570.1069.50200.91
Upgrade
PE Ratio
-----45.14
Upgrade
PS Ratio
25.5220.2419.5759.1262.4219.40
Upgrade
PB Ratio
4.503.573.085.994.5313.61
Upgrade
P/TBV Ratio
4.533.593.106.054.5713.77
Upgrade
P/FCF Ratio
--1835.64--142.64
Upgrade
P/OCF Ratio
--290.80--109.77
Upgrade
EV/Sales Ratio
23.0918.0017.1454.5956.2719.10
Upgrade
EV/EBITDA Ratio
-----58.45
Upgrade
EV/EBIT Ratio
-----65.02
Upgrade
EV/FCF Ratio
-141.99-1608.05--140.41
Upgrade
Debt / Equity Ratio
0.080.080.090.510.390.04
Upgrade
Debt / EBITDA Ratio
-----0.17
Upgrade
Debt / FCF Ratio
--52.50--0.42
Upgrade
Net Debt / Equity Ratio
-0.43-0.43-0.41-0.46-0.45-0.44
Upgrade
Net Debt / EBITDA Ratio
10.3210.3260.261.621.60-1.91
Upgrade
Net Debt / FCF Ratio
14.9314.93-244.213.421.69-4.59
Upgrade
Asset Turnover
0.150.150.120.060.060.75
Upgrade
Inventory Turnover
0.590.590.500.250.762.84
Upgrade
Quick Ratio
10.3510.359.541.9912.486.54
Upgrade
Current Ratio
12.7712.7711.942.2115.388.48
Upgrade
Return on Equity (ROE)
-7.69%-7.69%-2.09%-26.14%-30.39%36.08%
Upgrade
Return on Assets (ROA)
-4.00%-4.00%-1.74%-11.29%-15.18%13.71%
Upgrade
Return on Capital Employed (ROCE)
-7.10%-7.10%-3.50%-29.60%-22.00%19.80%
Upgrade
Earnings Yield
-1.80%-2.27%-0.68%-5.04%-6.47%2.22%
Upgrade
FCF Yield
-0.64%-0.80%0.05%-2.26%-5.94%0.70%
Upgrade
Buyback Yield / Dilution
-0.03%-0.03%-0.10%-1.50%-0.73%-15.82%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.